These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34922421)

  • 1. Effects of early medication treatment and metformin use for cancer prevention in diabetes patients: a nationwide sample cohort study in Korea using extended landmark time analysis.
    Seo HJ; Oh HS
    Epidemiol Health; 2021; 43():e2021103. PubMed ID: 34922421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription trends and the selection of initial oral antidiabetic agents for patients with newly diagnosed type 2 diabetes: a nationwide study.
    Liu CH; Chen ST; Chang CH; Chuang LM; Lai MS
    Public Health; 2017 Nov; 152():20-27. PubMed ID: 28719837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Use and the Risk of Cancer in Patients with Diabetes: A Nationwide Sample Cohort Study.
    Oh TK; Song IA
    Cancer Prev Res (Phila); 2020 Feb; 13(2):195-202. PubMed ID: 31699707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line pharmacotherapy for incident type 2 diabetes: Prescription patterns, adherence and associated costs.
    Campbell DJT; Campbell DB; Ogundeji Y; Au F; Beall R; Ronksley PE; Quinn AE; Manns BJ; Hemmelgarn BR; Tonelli M; Spackman E
    Diabet Med; 2021 Sep; 38(9):e14622. PubMed ID: 34133781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study.
    Ko SH; Kim DJ; Park JH; Park CY; Jung CH; Kwon HS; Park JY; Song KH; Han K; Lee KU; Ko KS;
    Medicine (Baltimore); 2016 Jul; 95(27):e4018. PubMed ID: 27399082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
    Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
    Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea.
    Kim HM; Kang MJ; Song SO
    Endocrinol Metab (Seoul); 2022 Dec; 37(6):929-937. PubMed ID: 36604960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study.
    Oh TK; Song IA
    Acta Diabetol; 2021 Jun; 58(6):771-778. PubMed ID: 33582839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea.
    Jang WI; Kim MS; Kang SH; Jo AJ; Kim YJ; Tchoe HJ; Park CM; Kim HJ; Choi JA; Choi HJ; Paik EK; Seo YS; Yoo HJ; Kang JK; Han CJ; Kim YJ; Kim SB; Ko MJ
    Oncotarget; 2017 Feb; 8(6):9587-9596. PubMed ID: 28077783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
    Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
    Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis.
    Kowall B; Rathmann W; Kostev K
    Diabetes Care; 2015 Jan; 38(1):59-65. PubMed ID: 25336750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trends in diabetes medication prescription and factors associated with metformin discontinuation in people with newly diagnosed type 2 diabetes: A national population-based study.
    Aguadé AS; Gastaldi-Ménager C; Fontaine P; Karsenty D; Fagot-Campagna A; Amadou C
    Diabet Med; 2021 Jul; 38(7):e14457. PubMed ID: 33176391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.
    Johnson JA; Majumdar SR; Simpson SH; Toth EL
    Diabetes Care; 2002 Dec; 25(12):2244-8. PubMed ID: 12453968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6-year follow-up study.
    Lin HC; Kachingwe BH; Lin HL; Cheng HW; Uang YS; Wang LH
    Pharmacotherapy; 2014 Jan; 34(1):36-45. PubMed ID: 23864581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study.
    Ki YJ; Kim HJ; Kim MS; Park CM; Ko MJ; Seo YS; Moon SM; Choi JA
    Cancer Res Treat; 2017 Jan; 49(1):29-36. PubMed ID: 27384155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic Medication, Statins and the Risk and Prognosis of Non-endometrioid Endometrial Cancer in Women with Type 2 Diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Urpilainen E; Läärä E; Hinkula M; Puistola U
    Anticancer Res; 2018 Jul; 38(7):4169-4178. PubMed ID: 29970546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
    Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G
    Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy.
    Melikian C; White TJ; Vanderplas A; Dezii CM; Chang E
    Clin Ther; 2002 Mar; 24(3):460-7. PubMed ID: 11952029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between ethnicity, language and metformin prescriptions in U.S. community health center patients with diabetes.
    Ezekiel-Herrera D; Marino M; Lucas JA; Datta R; Aceves B; Boston D; Heintzman J
    Prev Med; 2024 Aug; 185():108025. PubMed ID: 38834161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.